These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6604348)

  • 21. HLA antigens and thyroid autoantibodies in patients with Graves' disease and their first degree relatives.
    Mather BA; Roberts DF; Scanlon MF; Mukhtar ED; Davies TF; Smith BR; Hall R
    Clin Endocrinol (Oxf); 1980 Feb; 12(2):155-63. PubMed ID: 6893172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity by cluster analysis techniques of Graves' patients typed for HLA DR and IgG heavy chain markers.
    Frecker MF; Preus M; Kozma L; Krasrits E; Stenszky V; Balazś C; Farid NR
    Mol Biol Med; 1986 Feb; 3(1):63-71. PubMed ID: 3083192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA and Graves' disease in Koreans.
    Cho BY; Rhee BD; Lee DS; Lee MS; Kim GY; Lee HK; Koh CS; Min HK; Lee M
    Tissue Antigens; 1987 Sep; 30(3):119-21. PubMed ID: 3424333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies on the HLA system in Japanese patients with Graves' disease (author's transl)].
    Nakamura S
    Igaku Kenkyu; 1980 Feb; 50(2):111-28. PubMed ID: 6895437
    [No Abstract]   [Full Text] [Related]  

  • 25. [Human leukocyte antigen (HLA) complex and anti-thyroidal antibodies in Graves' disease].
    Lacka K; Kordel M; Gembicki M
    Pol Tyg Lek; 1989 Feb 13-20; 44(7-8):179-81. PubMed ID: 2682567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure to demonstrate cell-mediated immune responses to thyroid antigens in Graves' disease using in vitro assays of lymphokine-mediated migration inhibition.
    Ludgate ME; Ratanachaiyavong S; Weetman AP; Hall R; McGregor AM
    J Clin Endocrinol Metab; 1985 Jan; 60(1):98-102. PubMed ID: 3871093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA antigens in White and Black South African diabetics.
    Shires R; Maier G; Lustig A; Barnett P; Joffe BI; Seftel HC
    S Afr Med J; 1983 Dec; 64(28):1087-9. PubMed ID: 6582605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The HLA B w4/w6 diallelic system in Graves' disease.
    Farid NR; Barnard JM; Sampson L; Noel EP; Marshall WH
    Tissue Antigens; 1978 May; 11(5):394-8. PubMed ID: 581239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA haplotypes and susceptibility to Graves' disease.
    De Rosa G; Testa A; Mariani M; Purpura M; Giacomini D
    Horm Res; 1992; 37(4-5):176-9. PubMed ID: 1490660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Connection between HLA-B8 antigen and suppressor T-cell activity in Graves' disease.
    Balázs C; Stenszky V; Kozma L; Szerze P; Leövey A
    Transplant Proc; 1979 Jun; 11(2):1314. PubMed ID: 314175
    [No Abstract]   [Full Text] [Related]  

  • 31. HLA antigens in Asian Indian patients with Graves' disease.
    Tandon N; Mehra NK; Taneja V; Vaidya MC; Kochupillai N
    Clin Endocrinol (Oxf); 1990 Jul; 33(1):21-6. PubMed ID: 2401095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenetic markers in patients with Graves' disease.
    Schifferdecker E; Kühnl P; Schöffling K; Manfras B; Holzberger G; Spielmann W; Böhm BO
    Klin Wochenschr; 1991 Apr; 69(6):256-60. PubMed ID: 2038175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-polarized cell surface expression of HLA-A,B,C and HLA-DR antigens in Graves' thyroid follicle cells.
    Mölne J; Nilsson M; Jansson S; Hansson G; Ericson LE
    Autoimmunity; 1991; 10(3):189-99. PubMed ID: 1756224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA Bw46 and DR9 associations in Graves' disease of Chinese patients are age- and sex-related.
    Yeo PP; Chan SH; Thai AC; Ng WY; Lui KF; Wee GB; Tan SH; Lee BW; Wong HB; Cheah JS
    Tissue Antigens; 1989 Sep; 34(3):179-84. PubMed ID: 2595722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Familial Graves' disease with HLA].
    Nao TS; Du YS; Tian D
    Zhonghua Nei Ke Za Zhi; 1988 Jun; 27(6):352-4, 389-90. PubMed ID: 3197507
    [No Abstract]   [Full Text] [Related]  

  • 36. Japanese Graves' disease: association with HLA-Bw46.
    Naito S; Sasaki H; Arakawa K
    Endocrinol Jpn; 1987 Oct; 34(5):685-8. PubMed ID: 3436299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two major genes, linked to HLA and Gm, control susceptibility to Graves' disease.
    Uno H; Sasazuki T; Tamai H; Matsumoto H
    Nature; 1981 Aug; 292(5825):768-70. PubMed ID: 6894965
    [No Abstract]   [Full Text] [Related]  

  • 38. Thyrotropin receptor antibodies in black South African patients with Graves' disease and their response to medical therapy.
    Zouvanis M; Panz VR; Kalk WJ; Joffe BI
    J Endocrinol Invest; 1998 Dec; 21(11):771-4. PubMed ID: 9972678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strong Correlation between HLA and Clinical Course of Subacute Thyroiditis-A Report of the Three Siblings.
    Stasiak M; Lewiński A
    Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33138008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-DRB3*0101 is associated with Graves' disease in Jamaicans.
    Smikie MF; Pascoe RW; Barton E; Morgan O; Christian N; Dowe G; Roye-Green K; Bailey V; James O
    Clin Endocrinol (Oxf); 2001 Dec; 55(6):805-8. PubMed ID: 11895223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.